Budget Impact and Financial Analysis of Outpatient Dalbavancin in an Urban, Non-Teaching, Community Hospital
Outpatient dalbavancin utilization presents an opportunity to realize net positive reimbursement and minimize pharmacy drug acquisition costs. Our study suggests that dalbavancin utilization presents significant cost advantages over intravenous daptomycin in both short and long treatment durations and over oral linezolid in long durations.
Authors
- Mitesh S. Patel (ORCID: https://orcid.org/0000-0002-5997-9984)
- Karan Raja (ORCID: https://orcid.org/0000-0003-0173-3313)
- Mona Philips
- Brandon Chen (ORCID: https://orcid.org/0000-0002-6319-2228)
- Onrina Chandra
Institutions
- Rutgers, The State University of New Jersey (US)
- UMass Memorial Health Care (US)
- Environmental and Occupational Health Sciences Institute (US)
Publication Details
- Journal
- Clinical Drug Investigation
- Published
- 2025-10-08
- DOI
- https://doi.org/10.1007/s40261-025-01486-z
- Primary Topic
- Bacterial Identification and Susceptibility Testing
- Type
- article
- Field-Weighted Citation Impact
- 0.00